CN101716278A - Medicament for preventing and treating cancers and preparation method thereof - Google Patents

Medicament for preventing and treating cancers and preparation method thereof Download PDF

Info

Publication number
CN101716278A
CN101716278A CN200910263538A CN200910263538A CN101716278A CN 101716278 A CN101716278 A CN 101716278A CN 200910263538 A CN200910263538 A CN 200910263538A CN 200910263538 A CN200910263538 A CN 200910263538A CN 101716278 A CN101716278 A CN 101716278A
Authority
CN
China
Prior art keywords
cancer
medicine
thin slice
temperature
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910263538A
Other languages
Chinese (zh)
Inventor
黄金和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SICHUAN HANLIANG BIO-TECHNOLOGY DEVELOPMENT Co Ltd
Original Assignee
SICHUAN HANLIANG BIO-TECHNOLOGY DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SICHUAN HANLIANG BIO-TECHNOLOGY DEVELOPMENT Co Ltd filed Critical SICHUAN HANLIANG BIO-TECHNOLOGY DEVELOPMENT Co Ltd
Priority to CN200910263538A priority Critical patent/CN101716278A/en
Publication of CN101716278A publication Critical patent/CN101716278A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a medicament for preventing and treating cancers, comprising the following components in percentage by weight: grass Fritillaria: 40-55, corydalis: 10-25, red euphorbia: 1-10, euphorbia: 1-8, paris polyphylla: 5-20, genkanin: 1-8 and Chinese gall; gallnut: 10-25. The medicament clears away heat and toxic materials, expels toxicant, eliminates lumps, abreacts stagnation, regulates qi, suppresses pain, removes necrosis, promotes granulation, aerates, nourishes the liver and the kidney, supplements qi, nourishes yin, is suitable for treating various malignant tumors and has no toxic and side effect. The invention also provides a preparation method of the medicament for preventing and treating cancers.

Description

Give protection against cancer, control medicine of cancer and preparation method thereof
Technical field:
The present invention is relevant with medicine, and is relevant with the medicine that gives protection against cancer, controls cancer especially.
Background technology:
It is one of disease of contemporary refractory that cancer is seriously threatening the development of human life and society, waits to study so cancer still occupies whole world medical science key subjects.The origin cause of formation of cancer is very complicated on the one hand, environmental pollution, ozone layer attenuation, this three big key element of earth heat effect add that gene of human body self etc. cause the cancer patient to rise year by year, the gesture that does not subtract is arranged greatly, the whole world has 4/1000ths people to suffer from cancer every year, and the crowd who dies from cancer just occupies 2%.China has 1,600,000 people to suffer from advanced carcinoma every year, and the patient who dies from cancer reaches more than 130 ten thousand people.Continuous development along with the modernization science and technology, chemotherapy, radiotherapy and diversified cancer treating medicine have been invented aspect the cancer conquering, delayed millions upon millions of patients' life, yet also having, the whole world do not control cancer, the special effect medicine that As the medicine took effect, the symptoms lessened, people are expecting to occur fast, no pain can thoroughly be killed the new drug that cancerous cell has no side effect and occur, have the considerable part patient be not die from cancer but die from that the radiotherapy, the chemotherapy poison that can't bear to stand pay effect in kill cancer cell, also killed the human immunocyte.Another object of the present invention is for anti-cancer being provided, controlling the preparation method of the medicine of cancer.
Summary of the invention:
The objective of the invention is to have no side effect, give protection against cancer, control the medicine of cancer for a kind of heat-clearing and toxic substances removing, toxin expelling, swollen clearly eliminating stagnation, the analgesia of regulating the flow of vital energy, removing the necrotic tissue and promoting granulation, the kidney invigorating of ventilation liver, supplementing QI and nourishing YIN being provided, being applicable to the various malignant tumor of treatment.
The object of the present invention is achieved like this:
The present invention gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 40-55
Rhizoma Corydalis 10-25
Radix Knoxiae 1-10
Radix Kansui 1-8
Rhizoma Paridis 5-20
Flos Genkwa 1-8
Galla Chinensis 10-25.
Above-mentioned anti-cancer, control the medicine of cancer, comprise the component of following weight portion:
Bulbus Iphigeniae Indicae 45-51
Rhizoma Corydalis 15-17
Radix Knoxiae 3-7
Radix Kansui 3-5
Rhizoma Paridis 7-15
Flos Genkwa 3-5
Galla Chinensis 15-17.
The preparation method of the medicine that the present invention is anticancer, control cancer comprises the steps:
1) the fresh Bulbus Iphigeniae Indicae rhizome of annual maturation of gathering, selected diameter is a 5-10 centimetre of Bulbus Iphigeniae Indicae rhizome, peel off crust clear water wash clean, be cut into 1-2 millimeter thin slice and put into pot, add an amount of purify waste water boiled, boil with low baking temperature and to pick up airing in 3-5 minute, in calorstat, under 55 ℃ of-65 ℃ of temperature, dry by the fire to thin slice water content 35%-5%, select daily temperature at 35-40 ℃ fine day, allow thin slice under sunlight, shine 6-8 hour equably, guarantee that the water content of thin slice is used flour mill pulverizing granularity 0061-0.074 μ m (200-250 order) behind 1-2%;
2) other 6 flavor crude drug selects the mashed dry medical material of 2-3 growth and maturity, free from insect pests, no mould cleaning with clear water to cut into slices, in dehydrator under 55 ℃ of-65 ℃ of temperature freeze-day with constant temperature at least 72 hours, water content enters the flour mill pulverizing respectively at 3-5% and makes its granularity 0061-0.074 μ m;
3), batching in proportion, mix anticancer, anti-cancer medicine.
The processing of selecting for use of each former medicine can guarantee four prescriptions of medicine of the present invention; The one, can guarantee the quality and the drug effect of former medicine after selected; The 2nd, can remove harmful, noxious substance in the medical material behind 3-5 minute the decocting in water; The 3rd, constant temperature drying can be guaranteed the stable of the medical material property of medicine; The 4th, after the sun shines, can keep the color and luster of former medicine and strengthen the effect of medicine.
Bulbus Iphigeniae Indicae in the medicine of the present invention (Pseuhobuibus cremastraoseupleiones)
Composition: mucous is that glucose is joined mannan (gathering become at 2: 1 with glucose by revealing sugar).
Effect: sweet in the mouth cold in nature, hot slightly poisonous.Heat clearing away eliminating stagnation, heat-clearing and toxic substances removing.
Rhizoma Corydalis (Rnizomacoryd2iis)
Composition: contain multiple alkaloid, total amount 0.59%---0.74%.Wherein have: d---and corydaline (a---covyd22ine is a Rhizoma Corydalis first element), d1---and Tetrahydropalmatine (d1---tetrahydropalnatine is a tetrahydropalmatine), protopine (protopi---ne is Rhizoma Corydalis third number), 1---and the cleaning politics, economics, organization, and ideology coptisine (1---tetrahydrocoptisine is a Rhizoma Corydalis fourth element, d1---Tetrahydrocoptisine (being Rhizoma Corydalis riveting the eleventh of the twelve Earthly Branches element) 1---tetrathdrocolumbamine (1---tetranydrocolumbamine is a corydalis element in heptan), d---and boldine dimethyl ether (d---glaucine is Rhizoma Corydalis Wang Su, Rhizoma Corydalis element in the last of the ten Heavenly stems), a---the purple alkali (dehydrocoryhaiine is a Dehydrocorydaline first element etc.) of allocryptopine (a---allo---Oryptopine is a Rhizoma Corydalis element in the third of the twelve Earthly Branches) and dehydrogenation.
Radix Knoxiae (Rad1xknoxlae)
Composition: contain anthraquinone analog compound: dissociated anthraquinone class 0.56%, associativity anthraquinone class 0.25%.Get 4 kinds of anthraquinones and two kinds in machine acid from the alcohol extract of root, 3---the hydroxyl morindone (3---kydroxymorindone), damnacanthal (damna---cahtna1), Rubiadin (rubidin), 1,---2---methyl---6---methoxyl group anthraquinone, knoxiadin (knoxiadin) the fragrant acid in top by name (syringic acid) temporarily and some are the fixed structure organic acid not, contains carbohydrate content in addition for 3,5 one trihydroxies.
Effect: bitter in the mouth cold in nature is slightly poisonous.Removing fluid-retention by purgation, dispersing swelling and dissipating binds.
Radix Kansui (Radlzkahsi)
---(---euphorbol),---(a---euph---orbol) etc. for euphol for Radix Kansui sterol (tirucallol) a for r for euphol for composition: contain r.
Effect: bitter in the mouth cold in nature has attainment deep water by expectorant.
Rhizoma Paridis (Rhizoma paridis)
Composition: contain Saponin, sweet ruscogenin is diosgenin (diosgenin).Rhizoma Paridis (magnificent Rhizoma Paridis) rhizome contains the about 1.35% of dioscin, and contains diosgenin monobasic one tetrose glycoside, Rhizoma Dioscoreae soap unit monobasic rhamnose---arabinose---glycoside, pariphylin A, B (p2ripnyccinA, B); The Rhizoma Paridis rhizome contains the potato fragrant plant, and to tear to pieces glycoside unit about 2.14%, and contain pariphyllin (polyphyllin) 1.11, all partially ruscogenin (penn08enin), dioscin, B---molting hormone.Closely it is reported and tell 8 kinds of new steroid saponin monomers in the Paris polyphylla.
Effect: cold nature bitter in the mouth.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain, dispelling wind and relieving convulsion.
Flos Genkwa (Cfiosgenkwa)
Composition: flower contains genkwanin (gehkwanin) hydroxyl an aromatic plant metioned in ancient books genkwanin (hydroxygehkwanin) Yuanhuacin A. B, and (---nhuacinel) Flos Genkwa fat second (yuanuacinell) diterpene ortho acid fat Flos Genkwa fat third (yuanhuafine) diterpene ortho acid fat---la---formyloxy daphnetoxin (la---bihzocydaphnetoxin) still contains sitosterol benzoic acid and the zest malicious grease of being always or usually as specified to yua in addition.
Effect: warm in nature, acrid in the mouth is poisonous.The blood stasis dispelling of relieving oedema or abdominal distension through diuresis or purgation.
Galla Chinensis
Composition: have another name called the mosquito clam, originate in the river, lake, Zhejiang, Guangdong and Guangxi Provinces, Gansu, Shandong, each province, northeast.Bitter in the mouth acid, temperature, contain compositions such as tannic acid, fatty resin.
Function: astringe the lung bloated, end the juice leukorrhagia stopping, hemostasis is promoted the production of body fluid, and is strong astringent.Be applicable to that chronic enteritis, chronic dysentery are more than, spitting blood, hemoptysis, have blood in stool, all mass formed by blood stasis such as hematuria, hemorrhoidal bleeding and women's metrorrhagia, leucorrhea with red and white discharge, spontaneous perspiration, night sweat, be used for diseases such as wound hemorrhage, skin eczema, otitis media, stomatitis outward.
Effect: sterilization and anticorrosion, detumescence anastalsis are arranged.
More than seven flavor Chinese medicine preparations be monarch's (Bulbus Iphigeniae Indicae), minister (Rhizoma Corydalis), left (Radix Knoxiae), make (other four Chinese medicine) in curing the disease, respectively execute its duty to bring into play unusual synergism again.Monarch drug plays the effect of killing cancerous cell and heat clearing away, detoxicating; Ministerial drug plays various toxin in the human body, the effect that excretes; The effect that left side medicine has also played analgesia, invigorated blood circulation in auxiliary principal agent; Messenger drug is being brought into play supplementing QI and nourishing YIN, and the easing the affected liver the kidney invigorating strengthens the effect of immune function of human body.Prescription has embodied the marrow of Chinese medicine, tcm theory, promptly is that dialectical opinion disease is again the dialectical scientific tcm total concept of controlling of executing.
Medicine of the present invention can be made water preparation by middle routinely drug-decocting method, also can be made into granule, capsule or other dosage form.Medicine oral administration of the present invention, external.
The present invention has multiple efficacies such as heat-clearing and toxic substances removing, toxin expelling, dispersing swelling and dissipating binds, the analgesia of regulating the flow of vital energy, removing the necrotic tissue and promoting granulation, easing the affected liver the kidney invigorating, supplementing QI and nourishing YIN, is applicable to the various malignant tumor of treatment: skin carcinoma, nasopharyngeal carcinoma, esophageal carcinoma, pulmonary carcinoma, gastric cancer, hepatocarcinoma, intestinal cancer, breast carcinoma, cervical cancer, lymphatic cancer, the brain cancer, osteocarcinoma and acute and chronic leukemia etc.No toxicity, drug withdrawal do not rebound, do not recur, and to middle and terminal cancer effective percentage 95%, cure rate reaches more than 70% in clinical practice.
Introduce clinical example below:
1, yellow * *, man 54 years old, south, Chongqing paulownia people enlisted in 1974, and it is critically ill late period to be diagnosed as gastric cancer through Army Hospital in 1987, the about a basin of of the black stool of row behind the oral administration medicine of the present invention; Severe pain disappears, and healing after three months, health is very healthy strong so far;
2, old * *, man 55 years old, the moral village people is returned in the Zizhong County, Sichuan, is diagnosed as later period of hepatocarcinoma through Huaxi Hospital Attached to Sichuan Univ in 2003, and the bed of going home does not down rise, oral administration medicine medicine of the present invention was left the bed after six days, just went on foot in second day and watch the fish pond situation, the cancer bag disappears and has recovered health after three months, and the one family lives happy happy.
3, the king * *, woman 36 years old, people from Chengdu, Sichuan, be diagnosed as lymphatic cancer through a heavy bed Third Military Medical University (existing southwestern hospital) in 1996, oral administration medicine of the present invention was fully recovered after three months, gave birth to a boy with pregnancy after the restorative life of lover (engineer of Chengdu aircraft manufacturing company), one family's happiness of living.
4, Lee * *, woman 46 years old, Yingde County Sha Kou people from town, Guangdong Province was diagnosed as breast carcinoma in 2008 and has been transferred to lymph and can not cures and go home to recuperate through Germany and Britain the People's Hospital, rose on April 15th, 2009 oral medicine of the present invention and external application medicated powder after three days lump begin to disappear, be almost recovered after three months, recovered health fully, can work, graze cattle down and the work that does housework, family life be tranquil.
5, Soviet Union * *, man 45 years old, the suppression of Qingyuan City, Guangdong Province pond on a hill, be diagnosed as pulmonary carcinoma and be transferred to rib through the People's Hospital, Qingyuan City in 2008, can not cure and go home to recuperate, on June 18th, 2009 was played oral medicine of the present invention, after one month, sb.'s illness took a favorable turn, the check carcinoembryonic antigen is reduced to normal person's value by 137.1nl/ml through the People's Hospital, Qingyuan City, and treatment the chief physician shock very much, question closely what medicine that patient eats? and make patient hold on and take medicine.Patient's rehabilitation substantially at present can have been driven the motorcycle trip and has been engaged in general work.Owing to the patient that two more than ten years are clinical is too many, inconvenience exemplifies one by one, and most patients have medical record and photo to file.
The specific embodiment:
Embodiment 1:
Present embodiment 1 gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 45
Rhizoma Corydalis 15
Radix Knoxiae 3
Radix Kansui 3
Rhizoma Paridis 7
Flos Genkwa 3
Galla Chinensis 15.
The preparation method of above-mentioned anticancer, the medicine of controlling cancer comprises the steps:
1) the fresh Bulbus Iphigeniae Indicae rhizome of annual maturation of gathering, selected diameter is a 5-10 centimetre of Bulbus Iphigeniae Indicae rhizome, peel off crust clear water wash clean, be cut into 1-2 millimeter thin slice and put into pot, add an amount of purify waste water boiled, boil with low baking temperature and to pick up airing in 3-5 minute, 60 ℃ of calorstats of reuse dry by the fire to thin slice water content 3%-5%, select daily temperature at 35-40 ℃ fine day, allow thin slice under sunlight, shine 6-8 hour equably, guarantee that the water content of thin slice is used flour mill pulverizing granularity 0061-0.074 μ m behind 1-2%;
2) other 6 flavor crude drug is selected the mashed dry medical material of 2-3 growth and maturity, free from insect pests, is noly mouldly cleaned section with clear water, and with 60 ℃ of dehydrator freeze-day with constant temperature 72 hours, water content entered the flour mill pulverizing respectively at 3-5% and makes its granularity 0061-0.074 μ m;
3), batching in proportion, mix anticancer, anti-cancer medicine.
Embodiment 2:
Present embodiment 2 gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 51
Rhizoma Corydalis 17
Radix Knoxiae 7
Radix Kansui 5
Rhizoma Paridis 15
Flos Genkwa 5
Galla Chinensis 17.
Embodiment 3:
Present embodiment 3 gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 48
Rhizoma Corydalis 16
Radix Knoxiae 5
Radix Kansui 4
Rhizoma Paridis 11
Flos Genkwa 4
Galla Chinensis 16.
Embodiment 4:
Present embodiment 4 gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 40
Rhizoma Corydalis 10
Radix Knoxiae 1
Radix Kansui 1
Rhizoma Paridis 5
Flos Genkwa 1
Galla Chinensis 10.
Embodiment 5:
Present embodiment 5 gives protection against cancer, controls the medicine of cancer, comprises the component of following weight portion:
Bulbus Iphigeniae Indicae 55
Rhizoma Corydalis 25
Radix Knoxiae 10
Radix Kansui 8
Rhizoma Paridis 20
Flos Genkwa 8
Galla Chinensis 25.
The preparation method of present embodiment 2-embodiment 5 and embodiment 1 are together.
The foregoing description is that foregoing of the present invention is further described, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to the foregoing description.All technology that realizes based on foregoing all belong to scope of the present invention.

Claims (3)

1. give protection against cancer, control the medicine of cancer, comprise the component of following weight portion:
Bulbus Iphigeniae Indicae 40-55
Rhizoma Corydalis 10-25
Radix Knoxiae 1-10
Radix Kansui 1-8
Rhizoma Paridis 5-20
Flos Genkwa 1-8
Galla Chinensis 10-25.
2. anti-cancer as claimed in claim 1, control the medicine of cancer, it is characterized in that comprising the component of following weight portion:
Bulbus Iphigeniae Indicae 45-51
Rhizoma Corydalis 15-17
Radix Knoxiae 3-7
Radix Kansui 3-5
Rhizoma Paridis 7-15
Flos Genkwa 3-5
Galla Chinensis 15-17.
3. the preparation method of anticancer, the medicine of controlling cancer as claimed in claim 1 or 2 is characterized in that comprising the steps:
1) the fresh Bulbus Iphigeniae Indicae rhizome of annual maturation of gathering, selected diameter is a 5-10 centimetre of Bulbus Iphigeniae Indicae rhizome, peel off crust clear water wash clean, be cut into 1-2 millimeter thin slice and put into pot, add an amount of purify waste water boiled, boil with low baking temperature and to pick up airing in 3-5 minute, in calorstat, under 55 ℃ of-65 ℃ of temperature, dry by the fire to thin slice water content 35%-5%, select daily temperature at 35-40 ℃ fine day, allow thin slice under sunlight, shine 6-8 hour equably, guarantee that the water content of thin slice is used flour mill pulverizing granularity 0061-0.074 μ m behind 1-2%.
2) other 6 flavor crude drug selects the mashed dry medical material of 2-3 growth and maturity, free from insect pests, no mould cleaning with clear water to cut into slices, in dehydrator under 55 ℃ of-65 ℃ of temperature freeze-day with constant temperature at least 72 hours, water content enters the flour mill pulverizing respectively at 3-5% and makes its granularity 0061-0.074 μ m;
3), batching in proportion, mix anticancer, anti-cancer medicine.
CN200910263538A 2009-12-23 2009-12-23 Medicament for preventing and treating cancers and preparation method thereof Pending CN101716278A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910263538A CN101716278A (en) 2009-12-23 2009-12-23 Medicament for preventing and treating cancers and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910263538A CN101716278A (en) 2009-12-23 2009-12-23 Medicament for preventing and treating cancers and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101716278A true CN101716278A (en) 2010-06-02

Family

ID=42430975

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910263538A Pending CN101716278A (en) 2009-12-23 2009-12-23 Medicament for preventing and treating cancers and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101716278A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169055A (en) * 2015-09-28 2015-12-23 张光荣 Pharmaceutical preparation for treating cerebral cancer and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169055A (en) * 2015-09-28 2015-12-23 张光荣 Pharmaceutical preparation for treating cerebral cancer and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102784363A (en) Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof
CN104208245B (en) Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method
CN104815192A (en) Pharmaceutical composition for treating hypertension and application of pharmaceutical composition
CN103239662A (en) Parasite expelling Chinese herbal preparation for animals
CN105194421A (en) Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof
CN102293931A (en) Traditional Chinese medicinal composition, clinical preparation and preparation methods thereof
CN100536905C (en) Chinese-medicinal composition for treating stomachalgia
CN103845616A (en) Pharmaceutical composition for eliminating inflammation and disinfecting
CN101716278A (en) Medicament for preventing and treating cancers and preparation method thereof
CN102302655B (en) Loquat acne removing capsules
CN105617268A (en) Medicine for treating scale keratinization type beriberi
CN101829219B (en) Periplaneta Americana pharmaceutical composition for treating ulcerative colitis and preparation method thereof
CN105169149A (en) Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application
CN103860976B (en) A kind of pharmaceutical composition for the treatment of infant's dermatitis
CN103028028B (en) Traditional Chinese medicine agent for treating primary hepatic carcinoma
CN105560582A (en) Swelling eliminating and itch relieving ointment for treating chilblain and preparation method thereof
CN105288166A (en) Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof
CN105596848A (en) Preparation mainly for treating external hemorrhoids and preparing method thereof
CN105267745A (en) Traditional Chinese medicine composition for treating uremia and preparation method
CN105012595A (en) Traditional Chinese medicine composition for treating upper respiratory tract infection, and preparation method thereof
CN112516241A (en) Pharmaceutical composition for treating nasopharyngeal carcinoma and application thereof
CN111110806A (en) Broad-spectrum plant composition for treating colorectal cancer and preparation method and application method thereof
CN109106877A (en) A kind of prevention and treatment breast feeding women's heat evil stops up Chinese medicine composition, preparation method and the pharmaceutical preparation of Sheng type mazoitis
CN108524804A (en) A kind of Chinese medicine composition for treating pharyngo-laryngitis chronica
CN102657773A (en) Medicament for treating appendicitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20100602